Moreno-De-Luca, A. et al. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 12, 406–414 (2013).
Article PubMed PubMed Central Google Scholar
Khodosevich, K. & Sellgren, C. M. Neurodevelopmental disorders-high-resolution rethinking of disease modeling. Mol. Psychiatry 28, 34–43 (2023).
Murtaza, N. et al. Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies. Cell Rep. 41, 111678 (2022).
Article CAS PubMed Google Scholar
Nussinov, R., Tsai, C.-J. & Jang, H. How can same-gene mutations promote both cancer and developmental disorders? Sci. Adv. 8, eabm2059 (2022).
Article CAS PubMed PubMed Central Google Scholar
Jiang, C.-C. et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct. Target Ther. 7, 229 (2022).
Article PubMed PubMed Central Google Scholar
Parenti, I., Rabaneda, L.G., Schoen, H. & Novarino, G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 43, 608–621, (2020).
Article CAS PubMed Google Scholar
Qi, H., Dong, C., Chung, W. K., Wang, K. & Shen, Y. Deep genetic connection between cancer and developmental disorders. Hum. Mutat. 37, 1042–1050 (2016).
Article PubMed PubMed Central Google Scholar
Baranova, J. et al. Autism spectrum disorder: signaling pathways and prospective therapeutic targets. Cell. Mol. Neurobiol. 41, 619–649 (2021).
Crawley, J. N., Heyer, W.-D. & LaSalle, J. M. Autism and cancer share risk genes, pathways, and drug targets. Trends Genet. 32, 139–146 (2016).
Article CAS PubMed PubMed Central Google Scholar
Gabrielli, A. P., Manzardo, A. M. & Butler, M. G. GeneAnalytics pathways and profiling of shared autism and cancer genes. Int. J. Mol. Sci. 20, 1166 (2019).
Article CAS PubMed PubMed Central Google Scholar
Klaus, A. & Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8, 387–398 (2008).
Article CAS PubMed Google Scholar
Kwan, V., Unda, B. K. & Singh, K. K. Wnt signaling networks in autism spectrum disorder and intellectual disability. J. Neurodev. Disord. 8, 45 (2016).
Article PubMed PubMed Central Google Scholar
Lopes, R., Soares, R., Figueiredo-Braga, M. & Coelho, R. Schizophrenia and cancer: is angiogenesis a missed link? Life Sci. 97, 91–95 (2014).
Article CAS PubMed Google Scholar
Wen, Y. & Herbert, M. R. Connecting the dots: overlaps between autism and cancer suggest possible common mechanisms regarding signaling pathways related to metabolic alterations. Med. Hypotheses 103, 118–123 (2017).
Huang, K.-L. et al. Pathogenic germline variants in 10,389 adult cancers. Cell 173, 355–370.e14 (2018).
Article CAS PubMed PubMed Central Google Scholar
Liu, M. et al. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Transl. Lung Cancer Res. 9, 646–658 (2020).
Article CAS PubMed PubMed Central Google Scholar
Qing, T. et al. Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden. Nat. Commun. 11, 2438 (2020).
Article CAS PubMed PubMed Central Google Scholar
Rashed, W. M., Marcotte, E. L. & Spector, L. G. Germline de novo mutations as a cause of childhood cancer. JCO Precis. Oncol. https://doi.org/10.1200/PO.21.00505 (2022).
Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153–158 (2007).
Article CAS PubMed PubMed Central Google Scholar
Xu, X. et al. Germline genomic patterns are associated with cancer risk, oncogenic pathways, and clinical outcomes. Sci. Adv. 6, eaba4905 (2020).
Article CAS PubMed PubMed Central Google Scholar
Li, B. et al. De novo mutation of cancer-related genes associates with particular neurodevelopmental disorders. J. Mol. Med. 98, 1701–1712 (2020).
Article CAS PubMed Google Scholar
Koire, A. et al. A method to delineate de novo missense variants across pathways prioritizes genes linked to autism. Sci. Transl. Med. 13, eabc1739 (2021).
Article CAS PubMed PubMed Central Google Scholar
Nussinov, R. et al. Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR and PAK1-regulated MAPK. Biophys. Rev. https://doi.org/10.1007/s12551-023-01054-9 (2023).
Chiang, H.-L. et al. Risk of cancer in children, adolescents, and young adults with autistic disorder. J. Pediatr. 166, 418–423.e1 (2015).
Liu, Q. et al. Cancer risk in individuals with autism spectrum disorder. Ann. Oncol. 33, 713–719 (2022).
Article CAS PubMed Google Scholar
Kao, H.-T., Buka, S. L., Kelsey, K. T., Gruber, D. F. & Porton, B. The correlation between rates of cancer and autism: an exploratory ecological investigation. PLoS ONE 5, e9372 (2010).
Article PubMed PubMed Central Google Scholar
Chen, M.-H. et al. Cancer risk in patients with bipolar disorder and unaffected siblings of such patients: a nationwide population-based study. Int. J. Cancer 150, 1579–1586 (2022).
Article CAS PubMed Google Scholar
Singh, G., Driever, P. H. & Sander, J. W. Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 128, 7–17 (2005).
Singh, G., Fletcher, O., Bell, G. S., McLean, A. E. & Sander, J. W. Cancer mortality amongst people with epilepsy: a study of two cohorts with severe and presumed milder epilepsy. Epilepsy Res. 83, 190–197 (2009).
Jansson, A. K. et al. Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders. Br. J. Cancer 128, 2261–2269 (2023).
Article PubMed PubMed Central Google Scholar
Turner, T. N. et al. denovo-db: a compendium of human de novo variants. Nucleic Acids Res. 45, D804–D811 (2017).
Article CAS PubMed Google Scholar
Bragin, E. et al. DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res. 42, D993–D1000 (2014).
Article CAS PubMed Google Scholar
Abrahams, B. S. et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol. Autism 4, 1–3 (2013).
Piñero, J. et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database 2015, bav028 (2015).
Article PubMed PubMed Central Google Scholar
Lu, D. et al. A shared genetic contribution to breast cancer and schizophrenia. Nat. Commun. 11, 1–10 (2020).
Byrne, E. M. et al. Is schizophrenia a risk factor for breast cancer?-evidence from genetic data. Schizophr. Bull. 45, 1251–1256 (2019).
Anmella, G. et al. Risk of cancer in bipolar disorder and the potential role of lithium: international collaborative systematic review and meta-analyses. Neurosci. Biobehav. Rev. 126, 529–541 (2021).
Article CAS PubMed Google Scholar
Gao, X. et al. Glioma in schizophrenia: is the risk higher or lower? Front. Cell. Neurosci. 12, 399589 (2018).
Ge, F. et al. Association between schizophrenia and prostate cancer risk: results from a pool of cohort studies and Mendelian randomization analysis. Compr. Psychiatry 115, 152308 (2022).
Chou, F. H.-C., Tsai, K.-Y., Su, C.-Y. & Lee, C.-C. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr. Res. 129, 97–103 (2011).
Comments (0)